Search This Blog

Thursday, November 7, 2019

Karuna Therapeutics EPS beats by $0.08

Karuna Therapeutics (NASDAQ:KRTX): Q3 GAAP EPS of -$0.39 beats by $0.08.
Cash, equivalents and short-term investments of $161.61M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)